← Open Payments lookup

DAVID HERRING: Open Payments

NPI 1336640788 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$872 in 46 payments from 18 companies in 2025. Trend: 2023 $97 · 2024 $589 · 2025 $872

Food & beverage: $872
CompanyPaymentsAmount
Lilly USA, LLC7$122
ABBVIE INC.5$114
Novo Nordisk Inc6$106
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$84
AstraZeneca Pharmaceuticals LP3$65
Otsuka America Pharmaceutical, Inc.3$63
Astellas Pharma US Inc3$58
Corcept Therapeutics2$39
GlaxoSmithKline, LLC.2$38
Biogen, Inc.2$35

Products named: MOUNJARO, CAPLYTA, LEQEMBI, REXULTI, Veozah, QULIPTA, UBRELVY, Wegovy.

Industry payments across NC — which companies pay providers there.